Comment
doi: 10.1080/09546634.2020.1757605.
Epub 2020 Apr 27.
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears
Affiliations
- PMID: 32301363
- DOI: 10.1080/09546634.2020.1757605
Item in Clipboard
Comment
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears
J Dermatolog Treat.
2020 Jun.
Free article
No abstract available
Comment in
-
Patient's perspective: psychological burden of the COVID-19 pandemic in 146 psoriatic patients treated with biological drugs and small molecules in real clinical practice.J Dermatolog Treat. 2022 Mar;33(2):1185-1187. doi: 10.1080/09546634.2020.1790485. Epub 2020 Jul 9. J Dermatolog Treat. 2022. PMID: 32643475 No abstract available.
Comment on
-
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22. Dermatol Ther. 2020. PMID: 32157783 Free PMC article. No abstract available.
-
Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.J Dermatolog Treat. 2020 Jun;31(4):320-321. doi: 10.1080/09546634.2020.1749545. Epub 2020 Apr 6. J Dermatolog Treat. 2020. PMID: 32248724 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
